Therapeutic Gene Editing with CRISPR

Therapeutic gene editing with the clustered regularly interspaced short palindromic repeat (CRISPR) –Cas system offers significant improvements in specificity and programmability compared with previous methods. CRISPR editing strategies can be used ex vivo and in vivo with many theoretic disease applications. Off-target effects of CRISPR-mediated gene editing are an important outcome to be awa re of, minimize, and detect. The current methods of regulatory approval for personalized therapies are complex and may be proved inefficient as these therapies are implemented more widely. The role of pathologists and laboratory medicine practitioners is vital to the clinical implementation of thera peutic gene editing.
Source: Clinics in Laboratory Medicine - Category: Laboratory Medicine Authors: Source Type: research